Atlas Trials

A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

Clinical trial NCT05100472 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05100472
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2021-10-19
Primary completion
2026-10-19
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.